|
🐜
|
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
15 auth.
I. Garcia-Murillas,
G. Schiavon,
B. Weigelt,
C. Ng,
S. Hrebien,
R. Cutts,
M. Cheang,
P. Osin,
A. Nerurkar,
I. Kozarewa,
...
Javier Armisen Garrido,
M. Dowsett,
J. Reis-Filho,
I. Smith,
N. Turner
|
9 |
2015 |
9
🐜
|
|
🐜
|
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.
17 auth.
C. Fribbens,
B. O’Leary,
L. Kilburn,
S. Hrebien,
I. Garcia-Murillas,
M. Beaney,
M. Cristofanilli,
F. André,
S. Loi,
S. Loibl,
...
John Jiang,
C. H. Bartlett,
M. Koehler,
M. Dowsett,
J. Bliss,
S. Johnston,
N. Turner
|
9 |
2016 |
9
🐜
|
|
🐜
|
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
17 auth.
G. Schiavon,
S. Hrebien,
I. Garcia-Murillas,
R. Cutts,
A. Pearson,
N. Tarazona,
K. Fenwick,
I. Kozarewa,
E. López-Knowles,
Ricardo Ribas,
...
A. Nerurkar,
P. Osin,
S. Chandarlapaty,
L. Martin,
M. Dowsett,
I. Smith,
N. Turner
|
8 |
2015 |
8
🐜
|
|
🐜
|
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial.
13 auth.
B. O’Leary,
R. Cutts,
Yuan Liu,
S. Hrebien,
Xin Huang,
K. Fenwick,
F. André,
S. Loibl,
S. Loi,
I. Garcia-Murillas,
...
M. Cristofanilli,
C. Huang Bartlett,
N. Turner
|
8 |
2018 |
8
🐜
|
|
🐜
|
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
13 auth.
B. O’Leary,
S. Hrebien,
J. Morden,
M. Beaney,
C. Fribbens,
Xin Huang,
Yuan Liu,
C. H. Bartlett,
M. Koehler,
M. Cristofanilli,
...
I. Garcia-Murillas,
J. Bliss,
N. Turner
|
8 |
2018 |
8
🐜
|
|
🐜
|
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.
22 auth.
I. Garcia-Murillas,
N. Chopra,
I. Comino-Méndez,
M. Beaney,
H. Tovey,
R. Cutts,
C. Swift,
D. Kriplani,
M. Afentakis,
S. Hrebien,
...
Giselle Walsh-Crestani,
P. Barry,
S. Johnston,
A. Ring,
J. Bliss,
S. Russell,
A. Evans,
A. Skene,
D. Wheatley,
M. Dowsett,
I. Smith,
N. Turner
|
8 |
2019 |
8
🐜
|
|
🐜
|
Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer
15 auth.
C. Fribbens,
C. Fribbens,
I. G. Murillas,
M. Beaney,
S. Hrebien,
B. O’Leary,
L. Kilburn,
K. Howarth,
Michael Epstein,
E. Green,
...
N. Rosenfeld,
A. Ring,
S.R.D. Johnston,
N. Turner,
Nicholas C Turner
|
7 |
2018 |
7
🐜
|
|
🦁
|
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial
16 auth.
S. Hrebien,
Valentina Citi,
Valentina Citi,
I. Garcia-Murillas,
R. Cutts,
Kerry Fenwick,
I. Kozarewa,
Robert McEwen,
J. Ratnayake,
R. Maudsley,
...
TH Carr,
E. D. Bruin,
Gaia Schiavon,
Mafalda Oliveira,
N. Turner,
N. Turner
|
6 |
2019 |
6
🦁
|
|
🐜
|
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer
12 auth.
B. O’Leary,
R. Cutts,
Xin Huang,
S. Hrebien,
Yuan Liu,
F. André,
...
S. Loibl,
S. Loi,
I. Garcia-Murillas,
M. Cristofanilli,
C. H. Bartlett,
N. Turner
|
6 |
2020 |
6
🐜
|
|
🐜
|
Genomic profile of advanced breast cancer in circulating tumour DNA
24 auth.
B. Kingston,
R. Cutts,
H. Bye,
M. Beaney,
Giselle Walsh-Crestani,
S. Hrebien,
C. Swift,
L. Kilburn,
S. Kernaghan,
L. Moretti,
...
K. Wilkinson,
A. Wardley,
I. Macpherson,
R. Baird,
R. Roylance,
J. Reis-Filho,
M. Hubank,
I. Faull,
K. Banks,
R. Lanman,
I. Garcia-Murillas,
J. Bliss,
A. Ring,
N. Turner
|
6 |
2021 |
6
🐜
|
|
🐜
|
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis.
13 auth.
B. O’Leary,
S. Hrebien,
M. Beaney,
C. Fribbens,
I. Garcia-Murillas,
John Jiang,
Yuan Li,
C. Huang Bartlett,
F. André,
S. Loibl,
...
S. Loi,
M. Cristofanilli,
N. Turner
|
6 |
2019 |
6
🐜
|
